Welcome to our website Information Request Form


320.

HUMAN VAGINAL-ECTOCERVICAL TISSUE MODEL FOR MICROBICIDE IRRITATION STUDIES. Ayehunie1, S., Cannon1, C., Lamore1, S., Bellavance1, K., Kubilus1, J., LaBonte2, J., Owens2, C., Pudney3, J., Anderson2, D., Sodroski2, J., Klausner1, M. and Sheasgreen1, J. 1MatTek Corporation, Ashland, MA. 2Dana Farber Cancer Institute, Boston, MA. 3Brigham and Women’s Hospital, Boston, MA. Presented at Microbicides 2004, London, England, March 28-31, (2004).

Keywords: Acquired immunodeficiency syndrome (AIDS) , Basal, CD34+ , CD34+ precursor cells, Carrageenin-I, DC, Dendritic cells, EpiVaginal, FACS analysis , GM-CSF, Glycogenated intermediate, HIV, Il-1b, Langerhans cells , MTT, MTT ET-50 tissue viability assay, MTT assay, Methyl cellulose , Microbicidal ECV irritation, Microbicidal efficacy, Nonoxynol-9 (N-9), Normal, human ECV , Parabasal, Sexually transmitted disease (STD), Superficial cell layers, TNF-α, , Vaginal epithelium, Vaginal toxicity , Vaginal-ectocervical epithelial cells (VEC), Virucides

Endpoints: MTT Tissue viability assay

Materials Tested: Carrageenin-I, Methyl cellulose, Nonoxynol-9 (N-9)

Summary:
Infection through the vaginal-ectocervical (VEC) tissue is believed to be the main route for the heterosexual transmission of the human immunodeficiency virus (HIV) in women.

Recently, a tissue culture-based model of the VEC (EpiVaginal) has been developed. Normal, human VEC epithelial and dendritic cell co-cultures were used to form a three-dimensional tissue using specially formulated medium. The in vitro engineered tissue reproduces many of the histological and ultrastructural features including basal, parabasal, glycogenated intermediate, and the superficial cell layers.

Preliminary experiments by scientists at Dana Farber Cancer Institute (Boston, MA), Brigham and Women’s Hospital (Boston, MA) and MatTek Corp. showed the use of the EpiVaginal tissue model and the MTT tissue viability assay for predicting VEC irritation of microbicides.

Different concentrations of Nonoxynol-9 (N-9), carrageenin-I, and methyl cellulose were dosed topically and the viability of the VEC tissue was determine by MTT. Following 24 hr exposure to N-9 (0.1%) tissue viability was reduced to 51%. In contrast, carrageenin-I (20%) reduces viability to 77% and no effect was observed for methyl cellulose (up to 20%). H & E staining showed irritation of epithelial lining following N-9 treatment greater than or equal to 0.1%.

Experiments also showed that HIV virions do not pass freely through the tissue, but they infect cells in the reconstructed VEC tissue model containing dendritic cells.

In conclusion, the EpiVaginal tissue model is likely to serve as a useful tool to screen new or existing microbicides/formulations for vaginal toxicity and microbicidal efficacy.

====================

Request an Electronic Copy (PDF format) of this Technical Paper

====================

EpiVaginal Data Sheet

EpiVaginal Specifications

EpiVaginal Technical References



Site Map | Company Profile | Product Information | Contact Us
Home | Employment Opportunities | Technical Reference Search Technical References - All Products


"Ready-to-Use" TISSUE Basics:

New to "Ready-to-Use" TISSUE Technology?

Start Here:
Click on this Link